...
首页> 外文期刊>Archives of disease in childhood >Surveillance for fatal suspected adverse drug reactions in the UK.
【24h】

Surveillance for fatal suspected adverse drug reactions in the UK.

机译:在英国对致命的怀疑药物不良反应进行监视。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

AIM: To determine the nature and number of suspected adverse drug reactions (ADRs) associated with fatal outcomes in children reported through the yellow card scheme. METHODS: All reports of suspected ADRs with a fatal outcome in children received by the UK Committee on Safety of Medicines through its Yellow Card Scheme from 1964 until December 2000 were reviewed. Reports associated with vaccines and overdose were excluded. The medicine, date of the report, diagnosis, ADR, and the age of the child were analysed. No formal causality assessment was performed. RESULTS: There were 331 deaths with 390 suspected medicines reported for children aged 16 years or less. Medicines most frequently mentioned were anticonvulsants (65 deaths), cytotoxics (34 deaths), anaesthetic agents (30 deaths), and antibiotics (29 deaths). The individual drug most frequently mentioned was sodium valproate (31 deaths). The nature of the reported ADRs were diverse, with hepatic failure the most frequent. In the past decade, there has been an increase in both the total number of suspected ADRs reported in children and the number of reports with a fatal outcome. CONCLUSIONS: A wide range of suspected ADRs are associated with fatalities in children. Anticonvulsants were associated with the greatest number of reports of fatalities and hepatotoxicity in particular.
机译:目的:确定通过黄卡计划报告的与儿童致命结果相关的可疑药物不良反应(ADR)的性质和数量。方法:回顾了1964年至2000年12月间,英国药物安全委员会通过其黄卡计划收到的所有关于儿童可疑ADR的致命报告。与疫苗和过量相关的报道被排除在外。分析药物,报告日期,诊断,ADR和孩子的年龄。没有进行正式的因果关系评估。结果:针对16岁以下的儿童,有331人死亡,报告了390种可疑药物。最常提及的药物是抗惊厥药(65例死亡),细胞毒素(34例死亡),麻醉剂(30例死亡)和抗生素(29例死亡)。最常提及的药物是丙戊酸钠(31人死亡)。报告的ADR的性质多种多样,其中以肝衰竭最为常见。在过去的十年中,儿童中报告的可疑ADR总数和致命结果的报告数量均在增加。结论:广泛的可疑ADR与儿童死亡相关。抗惊厥药与死亡和肝毒性的报道最多有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号